TENIVAC (clostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)) injection, suspension [Sanofi Vaccines US Inc.]

21 Apr 20264 min read0 viewsVerified Feed

GIST

DailyMed Drug Label Updates published a clinical update in Pharmacology on 21 Apr 2026. The item focuses on TENIVAC (clostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)) injection, suspension [Sanofi Vaccines US Inc.]. Review the original article for the full source wording and details.

Clinical Editorial

Summary

DailyMed Drug Label Updates published a clinical update in Pharmacology on 21 Apr 2026.

The item focuses on TENIVAC (clostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)) injection, suspension [Sanofi Vaccines US Inc.].

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

BMJRelated by Specialty

Source

DailyMed Drug Label Updates

TENIVAC (clostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)) injection, suspension [Sanofi Vaccines US Inc.]

GIST

Clinical Editorial

Summary

Source Reference

Related by Condition/Drug

FDA Blocks Publication Of Studies On Covid-19 And Shingles Vaccines

MGC HEALTH: Class II recall update

FLUOCINONIDE: Class II recall update

CARBAMAZEPINE tablet [Cardinal Health 107, LLC]

GEM ANTIPERSPIRANT STICK COCONUT VANILLA (aluminum zirconium tetrachlorohydrex glycine) stick [Gem Products US LLC]